Department of Ophthalmology, "Victor Babeş" University of Medicine and Pharmacy Timișoara, Faculty of Medicine, Timişoara, Romania.
Department of Ophthalmology, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania; Alcor Ophthalmology Clinic, Bucharest, Romani.
Rom J Ophthalmol. 2023 Jul-Sep;67(3):267-274. doi: 10.22336/rjo.2023.44.
To compare the outcomes of transepithelial photorefractive keratectomy (transPRK) with femtosecond laser assisted in situ keratomileusis (FS-LASIK) for the correction of astigmatism on amblyopic eyes. The design was a retrospective interventional study on 37 eyes with hyperopic or mixed astigmatism and refractive amblyopia, which underwent transPRK or FS-LASIK. The patients were distributed into 2 groups according to the technique used. Data was collected from patient files and comparison between groups was performed. The main outcomes measured were corrected distance visual acuity (CDVA), sphere, cylinder, spherical equivalent (SEQ), efficiency and safety indexes. In the transPRK group, SEQ improved significantly after 1 month, from 2.08 ± 2.02D (p<0.01) to 0.125 ± 0.86D and at the 12 month visit to -0.04 ± 0.62D (p>0.05), sphere improved from 4.03 ± 1.44D preoperatively to 0.67 ± 0.9D at 1 month (p<0.05) and further to 0.44 ± 0.71 at 12 months (p<0.05). CDVA improved from 0.194 ± 0.11 logMAR to 0.115 ± 0.1 logMAR at the 1-year visit. Safety index after 1 month was 1.09 ± 0.2 and 1.12 ± 0.35 at the 1-year visit. Efficiency index was 0.95 ± 0.22 at 1 month and 1.03 ± 0.34 after 1 year. In FS-LASIK group, SEQ improved after 1 month, from 2.28 ± 3.04 to -0.79 ± 0.73D (p<0.01), and further to -0.49 ± 0.79 (p>0.05) at the 12 month visit, sphere improved from 4.11 ± 2.35D preoperatively to -0.42 ± 0.66D at 1 month (p<0.05) and further to -0.08 ± 0.75D at 12 months (p<0.05). CDVA also improved from 0.191 ± 0.1 logMAR to 0.140 ± 0.1 logMAR at 1 year. Safety index after 1 month was 1.1 ± 0.2 and 1.16 ± 0.21 at the 1-year visit. Efficiency index was 0.98 ± 0.27 at 1 month and 1.06 ± 0.23 after 1 year. Both procedures were safe and efficient in improving visual acuity for patients with mixed and hyperopic astigmatism and refractive amblyopia. transPRK = transepithelial photorefractive keratectomy, FS-LASIK = femtosecond laser in situ keratomileusis, logMAR = logarithm of the Minimum Angle of Resolution, BCVA = best corrected distance visual acuity, CDVA = corrected distance visual acuity.
比较经上皮准分子激光角膜切削术(transPRK)与飞秒激光原位角膜磨镶术(FS-LASIK)治疗弱视伴远视或混合散光的疗效。设计:回顾性干预性研究,纳入 37 例远视或混合散光伴屈光性弱视患者,分别行 transPRK 或 FS-LASIK。根据手术方式将患者分为 2 组。收集患者病历资料,比较两组间差异。主要观察指标:矫正视力(CDVA)、球镜、柱镜、等效球镜(SEQ)、效率和安全性指标。transPRK 组术后 1 个月 SEQ 显著改善,从术前 2.08 ± 2.02D 改善至术后 1 个月的 0.125 ± 0.86D(p<0.01)和术后 12 个月的 -0.04 ± 0.62D(p>0.05),术前球镜为 4.03 ± 1.44D,术后 1 个月改善至 0.67 ± 0.9D(p<0.05),术后 12 个月进一步改善至 0.44 ± 0.71D(p<0.05)。术后 1 年 CDVA 从术前的 0.194 ± 0.11 对数视力(logMAR)改善至 0.115 ± 0.1 logMAR。术后 1 个月安全性指数为 1.09 ± 0.2,术后 1 年为 1.12 ± 0.35。术后 1 个月效率指数为 0.95 ± 0.22,术后 1 年为 1.03 ± 0.34。FS-LASIK 组术后 1 个月 SEQ 改善,从术前 2.28 ± 3.04D 改善至 -0.79 ± 0.73D(p<0.01),术后 12 个月进一步改善至 -0.49 ± 0.79D(p>0.05),术前球镜为 4.11 ± 2.35D,术后 1 个月改善至 -0.42 ± 0.66D(p<0.05),术后 12 个月进一步改善至 -0.08 ± 0.75D(p<0.05)。术后 1 年 CDVA 也从术前的 0.191 ± 0.1 logMAR 改善至 0.140 ± 0.1 logMAR。术后 1 个月安全性指数为 1.1 ± 0.2,术后 1 年为 1.16 ± 0.21。术后 1 个月效率指数为 0.98 ± 0.27,术后 1 年为 1.06 ± 0.23。两种手术方式均可安全有效地改善混合性和远视性散光及屈光性弱视患者的视力。transPRK = 经上皮准分子激光角膜切削术,FS-LASIK = 飞秒激光原位角膜磨镶术,logMAR = 最小分辨角对数视力,BCVA = 最佳矫正远视力,CDVA = 矫正远视力。